Literature DB >> 19994845

Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore.

Marina Kritsanida1, Prokopios Magiatis, Alexios-Leandros Skaltsounis, Youyi Peng, Peng Li, Lawrence P Wennogle.   

Abstract

The bis-indole alkaloid indirubin and its analogues bear a very interesting natural pharmacophore. They are recognized mainly as kinase inhibitors, but several other activities make them possible candidates for preclinical studies. Based on the previously reported activity of 7-bromoindirubin-3'-oxime and its derivatives, the synthesis of indirubins bearing a heterocyclic nitrogen atom at position 7 was carried out. Herein, we report the first synthesis of 7-azaindirubin-3'-oxime (12) as well as its antiproliferative activity against 57 cancer cell lines and its inhibitory activity against a series of kinases. 7-Azaindirubin (10) and its 3'-oxime derivative (12) showed reduced activity as kinase inhibitors in comparison with other known indirubin derivatives, but antiproliferative activity with a best GI(50) value of 0.77 microM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19994845     DOI: 10.1021/np9003905

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Natural-Based Indirubins Display Potent Cytotoxicity toward Wild-Type and T315I-Resistant Leukemia Cell Lines.

Authors:  Nicolas Gaboriaud-Kolar; Vasillios Myrianthopoulos; Konstantina Vougogiannopoulou; Panagiotis Gerolymatos; David A Horne; Richard Jove; Emmanuel Mikros; Sangkil Nam; Alexios-Leandros Skaltsounis
Journal:  J Nat Prod       Date:  2016-10-11       Impact factor: 4.803

2.  Three-Component One-Pot Synthesis of Highly Functionalized Bis-Indole Derivatives.

Authors:  Xue-Bing Chen; Sheng-Li Xiong; Zhi-Xu Xie; Yong-Chao Wang; Wei Liu
Journal:  ACS Omega       Date:  2019-07-09

Review 3.  Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.

Authors:  Tina Blažević; Elke H Heiss; Atanas G Atanasov; Johannes M Breuss; Verena M Dirsch; Pavel Uhrin
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-17       Impact factor: 2.629

4.  Application of 7-azaisatins in enantioselective Morita-Baylis-Hillman reaction.

Authors:  Qing He; Gu Zhan; Wei Du; Ying-Chun Chen
Journal:  Beilstein J Org Chem       Date:  2016-02-18       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.